Previous 10 |
ISTOCK, BUBAONE We obtained approval of Clinical Trial Applications (CTA) in multiple countries for both β-thalassemia and sickle cell disease ((SCD)) and we continue to work closely with various clinical sites to initiate these trials. In parallel, we are working diligently wi...
The quarterly commentary for LMP Capital and Income Fund Inc. (NYSE: SCD) is now available. The portfolio management team from ClearBridge Investments, LLC (“ClearBridge”) discusses the Fund’s investment portfolio and market outlook. Investors can access the commenta...
LMP Capital and Income Fund Inc. (NYSE:SCD) announces its portfolio composition as of June 30, 2018. Investment Objective: The Fund’s Investment objective is total return with an emphasis on income. LMP Capital and Income Fund Inc., a non-diversified closed-end investment ma...
I've been striving for years now to find a fair and objective means of testing the relative merits of: the HYI strategy of investing in investments such as CEFs, BDCs, mREITS and MLPs which pay high dividends or distributions - typically over 8% per year. the DGI approach to investing in...
News, Short Squeeze, Breakout and More Instantly...
LMP Capital and Income Fund Inc. Company Name:
SCD Stock Symbol:
NYSE Market:
2024-07-04 10:06:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
Franklin Templeton Fund Adviser, LLC announced today that certain closed end funds have declared distributions pursuant to their managed distribution policy for the months of June, July and August 2024. The following dates apply to the distribution schedule below: (a) Please see table...
LMP Capital and Income Fund Inc. (the “Fund”) (NYSE: SCD) announced today the results of the votes cast at the Fund’s annual meeting of stockholders held April 12, 2024. Carol L. Colman, Daniel P. Cronin and Paolo M. Cucchi were elected as Class I Directors of the Fund by...